ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions.
The last earnings update was 13 days ago.
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
It is not possible to calculate the future cash flow value for
ReWalk Robotics. This is due to cash flow or dividend data being
unavailable. The share price is
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
is considered below, and whether this is a fair price.
Price based on past earnings
ReWalk Robotics's earnings available for a low price, and how does
this compare to other companies in the same industry?
ReWalk Robotics is not considered high growth as it is expected to be loss making for the next 1-3 years.
ReWalk Robotics's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
ReWalk Robotics's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Management is one of the most important areas of a company. We look at
unreasonable CEO compensation, how long the team and board of directors have
been around for and insider trading.
TENURE AS CEO
Mr. Lawrence J. Jasinski, also known as Larry, BS, MBA has been the Chief Executive Officer at ReWalk Robotics Ltd. (formerly Argo Medical Technologies) since February 2012. From 2005 to 2012, Mr. Jasinski served as President and Chief Executive Officer at Soteira, Inc., a company engaged in development and commercialization of products used to treat individuals with vertebral compression fractures, which was acquired by Globus Medical in 2012. He served as President and Chief Executive Officer at Cortek Inc. from 2001 to November 2005. From 1985 to 2001, Mr. Jasinski worked at Boston Scientific Corporation and served as its Vice President of Global Marketing, BSC Vascular, from 1998 to 2000. He serves as a Director at LeMaitre Vascular, Inc. since 2003 and ReWalk Robotics Ltd. since February 2012. He served as a Director of Cortek, Inc. Mr. Jasinski is also a member of the Board of Directors for Massachusetts Bay Lines, since 2015. Mr. Jasinski received his BS in Marketing from Providence College and his MBA from the University of Bridgeport.
Larry's compensation has been consistent with company performance over the past year, both up more than 20%.
Larry's remuneration is higher than average for companies of similar size in Germany.
Management Team Tenure
Average tenure and age of the
management team in years:
The average tenure for the ReWalk Robotics management team is less than 2 years, this suggests a new team.
CEO & Director
Chief Financial Officer
Vice President of QA & Operations
Vice President of Sales & Reimbursement
Vice President of Marketing
Vice President of Customer Service
Executive Advisor to the CEO
Board of Directors Tenure
Average tenure and age of the
board of directors in years:
The tenure for the ReWalk Robotics board of directors is about average.
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe. It is also developing ReWalk Restore, a soft suit exoskeleton for individuals who have suffered a stroke. ReWalk Robotics Ltd. markets and sells its products directly to third party payers, institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was founded in 2001 and is headquartered in Yokne'am Illit, Israel.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.